Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

导出 OA

翻译打印收藏纠错

作者： Esranur,Aydın ^[1] ; Ünal Metin,Tokat ^[1] ; Eylül,Özgü ^[1] ; Ashkan,Adibi ^[1] ; Onur,Tutar ^[2] ; Razelle,Kurzrock ^[3] ; Mutlu,Demiray ^[4]

作者单位： Demiray Precision Oncology Center, Medicana Health Group, Istanbul, Turkey. ^[1] Division of Cancer Genetics, Department of Basic Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey. ^[2] Cerrahpaşa Faculty of Medicine, Department of Radiology, Istanbul University-Cerrahpasa, Istanbul, Turkey. ^[3] Department of Medicine, Division of Hematology & Oncology, Medical College of Wisconsin, 9200 W, Wisconsin Ave, Milwaukee, WI 53226, USA. ^[4] Demiray Precision Oncology Center, Medicana Health Group, Küçükbakkalköy, Vedat Günyol Cd. No. 24, Ataşehir, Istanbul 34750, Turkey. ^[5]

关键词 CDH1 CDKN2A/B FGFR2 case report cholangiocarcinoma crizotinib palbociclib pazopanib precision oncology targeted therapy

DOI 10.1177/17588359241247023

PMID 38645422

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in medical oncology

2024年16卷

17588359241247023页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

检索历史清除